Eunjoon Kim
Neuroscientist who directs the IBS Center for Synaptic Brain Dysfunctions and studies synaptic scaffold proteins linked to autism; he contributed to work linking neuronal ERBB4 and mTOR signalling to Alzheimer's pathology
Professor, KAIST Department of Biological Sciences · Director, IBS Center for Synaptic Brain Dysfunctions · over 200 papers · Asan Award in Medicine (2018), POSCO TJ Park Prize (2013)
Center for Synaptic Brain Dysfunctions, Institute for Basic Science & Department of Biological Sciences, KAIST (Daejeon, South Korea) ↗ ORCID0000-0001-5518-6584 ↗
Portrait: IBS Center for Synaptic Brain Dysfunctions
Eunjoon Kim built his career mapping the molecular architecture of the synapse — in particular the SHANK family of postsynaptic scaffold proteins, whose mutations are among the best-established genetic causes of autism spectrum disorder. He now directs the IBS Center for Synaptic Brain Dysfunctions at KAIST, with over 200 papers published.
In this 2026 Nature paper from Won-Suk Chung's group (also at KAIST/IBS), Kim is a co-author on work showing that aberrant ERBB4 expression in excitatory neurons drives synapse loss, amyloid deposition, and cognitive decline via mTOR signaling — connecting his long-standing expertise in synaptic biology to the molecular front lines of neurodegeneration.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | A | Aberrant excitatory neuronal ERBB4 promotes Alzheimer's disease pathology LEE2026 Co-author (director, IBS Center for Synaptic Brain Dysfunctions; KAIST) on a 2026 Nature study showing aberrant ERBB4 expression in excitatory neurons drives Alzheimer's-like synapse loss and pathology via mTOR signaling. |
Co-authors in the Atlas 3
People with a profile here who share at least one study with Eunjoon Kim.
ShowHide
- Se Young Lee Neuroscientist in Won-Suk Chung's group at KAIST and the Institute for Basic Science who studies how neurons, astrocytes and immune cells interact in Alzheimer's disease, and first author of the 2026 Nature study on ERBB4 in excitatory neurons
- Seongbin Kim Contributed to a 2026 study showing that abnormal ERBB4 in excitatory neurons drives Alzheimer's pathology through mTOR signalling
- Won-Suk Chung Neuroscientist who studies how glial cells (astrocytes and microglia) shape synapses, and senior author of the 2026 study linking neuronal ERBB4 and mTOR signaling to early Alzheimer's disease changes in mice
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.